Skip to main content
Erschienen in: Rheumatology International 7/2022

07.01.2022 | Case Based Review

Hypercalcemia in IgG4-related disease: coincidental or associated? Case based review

verfasst von: Döndü Üsküdar Cansu, Güven Barış Cansu, Reşit Yildirim, Mustafa Dinler, Emel Tekin, İlknur Ak Sivrikoz, Cengiz Korkmaz

Erschienen in: Rheumatology International | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

Abstract

Immunoglobulin (Ig) G4-related disease (IgG4RD) is a chronic autoimmune disorder characterized by dense lymphoplasmacytic infiltrations and fibrosis of storiform pattern. The most typical manifestations include major salivary or lacrimal gland involvement, autoimmune pancreatitis, and retroperitoneal fibrosis. While the increase in IgG4 is the typical feature of the disease, hypercalcemia has been rarely reported in IgG4RD so far, only one of these cases has been shown parathyroid gland involvement (isolated involvement). In this study, we present a 43-year-old female patient with weight loss, pancreatic mass, lymphadenopathy, nodular lesion in the lung, hypercalcemia, and also increased level of serum IgG4. Histopathological investigation following parathyroidectomy revealed a dense lymphoplasmacytic infiltrate with an IgG4 to IgG ratio of > 50% in the fat tissue surrounding the parathyroid gland, particularly at the perivascular areas. This is the first systemic IgG4RD case in combination with hypercalcemia in the literature who was detected to have parathyroid adenoma. Our aim in this review is to emphasize that, although rarely, IgG4RD may be accompanied by hypercalcemia and parathyroid gland may be one of its target sites.
Literatur
1.
Zurück zum Zitat Perugino CA, Stone J (2020) IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol 16(12):702–714CrossRef Perugino CA, Stone J (2020) IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol 16(12):702–714CrossRef
2.
Zurück zum Zitat Maritati F, Peyronel F, Vaglio A (2020) IgG4-related disease: a clinical perspective. Rheumatology (Oxford) 59(Suppl 3):iii123–iii131CrossRef Maritati F, Peyronel F, Vaglio A (2020) IgG4-related disease: a clinical perspective. Rheumatology (Oxford) 59(Suppl 3):iii123–iii131CrossRef
3.
Zurück zum Zitat Karadeniz H, Vaglio A (2020) IgG4-related disease: a contemporary review. Turk J Med Sci 50(SI-2):1616–1631CrossRef Karadeniz H, Vaglio A (2020) IgG4-related disease: a contemporary review. Turk J Med Sci 50(SI-2):1616–1631CrossRef
4.
Zurück zum Zitat Amirbaigloo A, Esfahanian F, Mouodi M, Rakhshani N, Zeinalizadeh M (2021) IgG4-related hypophysitis. Endocrine 73(2):270–291CrossRef Amirbaigloo A, Esfahanian F, Mouodi M, Rakhshani N, Zeinalizadeh M (2021) IgG4-related hypophysitis. Endocrine 73(2):270–291CrossRef
5.
Zurück zum Zitat Hasegawa S, Mine S, Hagiwara S (2015) IgG4-related disease combined with autoimmune hemolytic anemia and steroid-responsive transient hypercalcemia. Clin Med Insights Case Rep 10(8):51–55 Hasegawa S, Mine S, Hagiwara S (2015) IgG4-related disease combined with autoimmune hemolytic anemia and steroid-responsive transient hypercalcemia. Clin Med Insights Case Rep 10(8):51–55
6.
Zurück zum Zitat Kawakita C, Kinomura M, Gon Y, Okita C, Katayama K, Nishikawa M, Shimada N, Notohara K, Fukushima M, Asano K (2019) A case of fatal osteolytic hypercalcemia complicated with IgG4-related ophthalmic disease leading to renal failure. CEN Case Rep 8(1):23–30CrossRef Kawakita C, Kinomura M, Gon Y, Okita C, Katayama K, Nishikawa M, Shimada N, Notohara K, Fukushima M, Asano K (2019) A case of fatal osteolytic hypercalcemia complicated with IgG4-related ophthalmic disease leading to renal failure. CEN Case Rep 8(1):23–30CrossRef
7.
Zurück zum Zitat Medina JE, Randolph GW, Angelos P, Zafereo ME, Tufano RP, Kowalski LP, Montenegro FLM, Owen RP, Khafif A, Suárez C, Shaha AR, Rodrigo JP, Krempl GA, Rinaldo A, Silver CE, Ferlito A (2021) Primary hyperparathyroidism: a disease of diverse genetic, symptomatic, and biochemical phenotypes. Head Neck. https://doi.org/10.1002/hed.26861 (Online ahead of print)CrossRefPubMed Medina JE, Randolph GW, Angelos P, Zafereo ME, Tufano RP, Kowalski LP, Montenegro FLM, Owen RP, Khafif A, Suárez C, Shaha AR, Rodrigo JP, Krempl GA, Rinaldo A, Silver CE, Ferlito A (2021) Primary hyperparathyroidism: a disease of diverse genetic, symptomatic, and biochemical phenotypes. Head Neck. https://​doi.​org/​10.​1002/​hed.​26861 (Online ahead of print)CrossRefPubMed
8.
Zurück zum Zitat Veress B, Nordenström J (1994) Lymphocytic infiltration and destruction of parathyroid adenomas: a possible tumour-specific autoimmune reaction in two cases of primary hyperparathyroidism. Histopathology 25(4):373–377CrossRef Veress B, Nordenström J (1994) Lymphocytic infiltration and destruction of parathyroid adenomas: a possible tumour-specific autoimmune reaction in two cases of primary hyperparathyroidism. Histopathology 25(4):373–377CrossRef
9.
Zurück zum Zitat Kovacs K, Bell CD, Juco J, Rotondo F, Anderson J (2007) Parathyroid chief cell adenoma associated with massive chronic parathyroiditis in a woman with hyperparathyroidism. Endocr Pathol 18(1):42–45CrossRef Kovacs K, Bell CD, Juco J, Rotondo F, Anderson J (2007) Parathyroid chief cell adenoma associated with massive chronic parathyroiditis in a woman with hyperparathyroidism. Endocr Pathol 18(1):42–45CrossRef
10.
Zurück zum Zitat Jung M, Bae JM, Jeon YK, Jung KC, Cho SW, Won JK (2019) Parathyroid adenoma with prominent lymphocytic infiltrate having histological features highly suggestive of IgG4-related disease: a case report and literature review. Endocr J 66(4):379–385CrossRef Jung M, Bae JM, Jeon YK, Jung KC, Cho SW, Won JK (2019) Parathyroid adenoma with prominent lymphocytic infiltrate having histological features highly suggestive of IgG4-related disease: a case report and literature review. Endocr J 66(4):379–385CrossRef
11.
Zurück zum Zitat Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409–1417CrossRef Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409–1417CrossRef
13.
Zurück zum Zitat Pallais JC, Kifor O, Chen YB, Slovik D, Brown EM (2004) Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor. N Engl J Med 351(4):362–369CrossRef Pallais JC, Kifor O, Chen YB, Slovik D, Brown EM (2004) Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor. N Engl J Med 351(4):362–369CrossRef
14.
Zurück zum Zitat Catalano A, Chilà D, Bellone F, Nicocia G, Martino G, Loddo I, Morabito N, Benvenga S, Loddo S (2018) Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? J Clin Transl Endocrinol 13:9–13PubMedPubMedCentral Catalano A, Chilà D, Bellone F, Nicocia G, Martino G, Loddo I, Morabito N, Benvenga S, Loddo S (2018) Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? J Clin Transl Endocrinol 13:9–13PubMedPubMedCentral
Metadaten
Titel
Hypercalcemia in IgG4-related disease: coincidental or associated? Case based review
verfasst von
Döndü Üsküdar Cansu
Güven Barış Cansu
Reşit Yildirim
Mustafa Dinler
Emel Tekin
İlknur Ak Sivrikoz
Cengiz Korkmaz
Publikationsdatum
07.01.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 7/2022
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-021-05076-y

Weitere Artikel der Ausgabe 7/2022

Rheumatology International 7/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

04.06.2024 Typ-2-Diabetes Nachrichten

Wenn ältere Menschen mit Typ-2-Diabetes Schwierigkeiten beim Beschaffen und Zubereiten von Mahlzeiten haben, geht dies mit einem deutlich gesteigerten Risiko für schwere Hypoglykämien einher.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.